Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0001822 |
IEA |
kidney development |
GO:0001974 |
TAS |
blood vessel remodeling |
GO:0001991 |
ISS |
regulation of systemic arterial blood pressure by circulatory renin-angiotensin |
GO:0002018 |
IEA |
renin-angiotensin regulation of aldosterone production |
GO:0002033 |
IEA |
vasodilation by angiotensin involved in regulation of systemic arterial blood pressure |
GO:0002035 |
IEA |
brain renin-angiotensin system |
GO:0004930 |
IEA |
G-protein coupled receptor activity |
GO:0004945 |
IPI |
angiotensin type II receptor activity |
GO:0005515 |
IPI |
protein binding |
GO:0005576 |
TAS |
extracellular region |
GO:0005886 |
TAS |
plasma membrane |
GO:0005887 |
IC |
integral component of plasma membrane |
GO:0006883 |
IEA |
cellular sodium ion homeostasis |
GO:0006954 |
IEA |
inflammatory response |
GO:0007166 |
IDA |
cell surface receptor signaling pathway |
GO:0007186 |
IC:IEA |
G-protein coupled receptor signaling pathway |
GO:0007199 |
ISS |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger |
GO:0007263 |
IC |
nitric oxide mediated signal transduction |
GO:0007420 |
NAS |
brain development |
GO:0008134 |
IEA |
transcription factor binding |
GO:0008217 |
TAS |
regulation of blood pressure |
GO:0008284 |
IEA |
positive regulation of cell proliferation |
GO:0010243 |
IEA |
response to organonitrogen compound |
GO:0010459 |
ISS |
negative regulation of heart rate |
GO:0010700 |
IEA |
negative regulation of norepinephrine secretion |
GO:0016021 |
IEA |
integral component of membrane |
GO:0017046 |
IEA |
peptide hormone binding |
GO:0021695 |
IEA |
cerebellar cortex development |
GO:0030308 |
TAS |
negative regulation of cell growth |
GO:0032304 |
IEA |
negative regulation of icosanoid secretion |
GO:0032516 |
IDA |
positive regulation of phosphoprotein phosphatase activity |
GO:0035556 |
ISS |
intracellular signal transduction |
GO:0035566 |
IEA |
regulation of metanephros size |
GO:0035640 |
IEA |
exploration behavior |
GO:0035815 |
IEA |
positive regulation of renal sodium excretion |
GO:0035932 |
IEA |
aldosterone secretion |
GO:0038166 |
IEA |
angiotensin-activated signaling pathway |
GO:0042416 |
IEA |
dopamine biosynthetic process |
GO:0042990 |
IEA |
regulation of transcription factor import into nucleus |
GO:0043537 |
NAS |
negative regulation of blood vessel endothelial cell migration |
GO:0045429 |
IC |
positive regulation of nitric oxide biosynthetic process |
GO:0045893 |
IEA |
positive regulation of transcription, DNA-templated |
GO:0045909 |
IDA |
positive regulation of vasodilation |
GO:0048019 |
TAS |
receptor antagonist activity |
GO:0048147 |
IEA |
negative regulation of fibroblast proliferation |
GO:0048471 |
IEA |
perinuclear region of cytoplasm |
GO:0050715 |
IEA |
positive regulation of cytokine secretion |
GO:0051000 |
ISS |
positive regulation of nitric-oxide synthase activity |
GO:0051387 |
IMP |
negative regulation of neurotrophin TRK receptor signaling pathway |
GO:0060993 |
IEA |
kidney morphogenesis |
GO:0061049 |
IEA |
cell growth involved in cardiac muscle cell development |
GO:0071549 |
IEA |
cellular response to dexamethasone stimulus |
GO:0072300 |
IEA |
positive regulation of metanephric glomerulus development |
GO:0090190 |
IEA |
positive regulation of branching involved in ureteric bud morphogenesis |
GO:1900116 |
TAS |
extracellular negative regulation of signal transduction |
GO:2001238 |
IMP |
positive regulation of extrinsic apoptotic signaling pathway |